REDWOOD CITY, Calif. – December 10, 2024 – LVMH RECHERCHE, the LVMH Beauty R&D Division, and Integrated Biosciences today announced a strategic research partnership to discover novel chemical entities that target aging at the molecular level. This multi-year partnership will leverage Integrated Biosciences’ synthetic biology and artificial intelligence (AI)-based platform for science-backed skin youth and beauty products.

Thanks to a combination of its proprietary AI and optogenetics platforms, Integrated Biosciences can train state-of-the-art deep learning models to virtually screen hundreds of thousands of molecules, identifying the most promising first-in-class chemical compounds that potently modulate age-related biological phenotypes.

The company has consistently reported on its drug discovery engine in leading scientific journals, including Nature Aging, Nature, and Cell Systems. Founded by scientists at MIT, Harvard University, and the University of California Santa Barbara and having recently announced a fundraise led by Sutter Hill Ventures, Integrated Biosciences is known for pioneering the AI-driven discovery of novel senolytic compounds – an anti-aging chemical entities that selectively clear pathological senescent “zombie” cells.

“Our partnership with Integrated Biosciences perfectly embodies our vision: to expand the frontiers of scientific discovery, fueling transformative innovations in beauty” said Bruno Bavouzet, President of LVMH Recherche. “This represents a unique opportunity to evaluate thousands of potential bioactives concurrently, revolutionizing the pace of our research for the benefit of all our brands, amongst them our flagship – Maison Parfums Christian Dior. By combining our skin research expertise with their AI and aging research, we are taking a decisive step in understanding and molecularly addressing age-related cellular pathways.”

“ Our partnership with Integrated Biosciences perfectly embodies our vision: to expand the frontiers of scientific discovery, fueling transformative innovations in beauty.
— Bruno Bavouzet, President of LVMH Recherche

“This collaboration with LVMH RECHERCHE, a global leader in luxury consumer product R&D, represents a significant step forward in our shared commitment to combating aging through cutting-edge science,” said Felix Wong, Ph.D., co-founder and CEO of Integrated Biosciences. “We are excited to integrate our proprietary technology platform with LVMH RECHERCHE’s scientific programs, leveraging our ability to control biological stress responses to develop novel, targeted bioactive molecules. Our combined efforts have the potential to unlock biologically functional products that could transform how people age.”

“ We are excited to integrate our proprietary technology platform with LVMH RECHERCHE’s scientific programs, leveraging our ability to control biological stress responses to develop novel, targeted bioactive molecules.
— Felix Wong, Ph.D., co-founder and CEO of Integrated Biosciences

Under the terms of the agreement, Integrated Biosciences is eligible to receive payments based on the achievement of certain near-term discovery, development, and commercial milestones. Financial terms of the collaboration were not disclosed.

About LVMH RECHERCHE